Skip to main content
Caplight Logo









MetaModix

MetaModix

Private
Plymouth, MinnesotaHealthcare & Life Scienceshttp://metamodix.com/

Last Round

VC Round

Jan 26, 2023

Total Funding Raised

$5.24M

Company Overview

MetaModix is a biotechnology company that develops nonsurgical, drug-free device therapies for the treatment of metabolic diseases including Type 2 Diabetes, obesity, and NASH.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicegastrointestinal implantmetabolic diseasebariatric surgery alternativeendoscopic deviceminimally invasive surgeryweight loss devicenonalcoholic steatohepatitisNASHType 2 diabetesinterventional gastroenterologymedtechobesity treatmentendoluminal therapybioelectronics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MetaModix Comparables

Compare MetaModix with similar companies based on industry and business-model similarity.

MetaModix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Keyron Medical Technology
91%
Morphic Medical
88%
GI Windows Surgical
83%

MetaModix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 26, 2023
Series AMar 28, 2017
Series AJun 24, 2015
VC RoundApr 7, 2014
VC RoundMar 28, 2013
Seed
Feb 15, 2012

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 28, 2017

    $1.2M round raised

  • Jun 24, 2015

    Raised $1.75M in Series A funding.

MetaModix Filings

Explore SEC and related filing metadata, where available.

MetaModix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MetaModix's valuation, stock price, and market status.

Is MetaModix a public or private company?

MetaModix is a private company.

What is the current stock price of MetaModix?

MetaModix is a private company with no public stock price. No recent secondary market data is available.

How much is MetaModix worth (valuation)?

Valuation information for MetaModix is not publicly available.

Can I buy MetaModix stock?

MetaModix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MetaModix's last funding round?

Funding round information for MetaModix is not publicly available.

Who are the main investors in MetaModix?

Investor information for MetaModix is not publicly disclosed.

Will MetaModix IPO soon?

No public IPO plans have been announced for MetaModix.

How can I track MetaModix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MetaModix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPlymouth, Minnesota
Employee Range3
Year Founded2009
Last FundingJan 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?